Of Mice and Men and Nonalcoholic Steatohepatitis
David A. Brenner – 23 July 2018
Antiprogrammed Cell Death‐1 Immunotherapy‐Related Secondary Sclerosing Cholangitis
Kohei Ogawa, Kenya Kamimura, Shuji Terai – 23 July 2018
Project ECHO: The Specialist Will See You Now
Saira Khaderi, Norman Sussman, Fasiha Kanwal – 23 July 2018
Issue Information ‐ Meeting Notices
23 July 2018
Shunts and bypasses for portal hypertension: Making the right choice
Riccardo Superina – 23 July 2018
Old Remedies to Heal the Liver: Novel Effects of Digoxin in Hepatic Sterile Inflammation
Juan P. Arab, Marco Arrese – 23 July 2018
The middle hepatic vein controversy: Art and science
Chung Mau Lo – 23 July 2018
Inhibition of Cyclin‐Dependent Kinase 5: A Strategy to Improve Sorafenib Response in Hepatocellular Carcinoma Therapy
Maximilian A. Ardelt, Thomas Fröhlich, Emanuele Martini, Martin Müller, Veronika Kanitz, Carina Atzberger, Petra Cantonati, Martina Meßner, Laura Posselt, Thorsten Lehr, Jan‐Georg Wojtyniak, Melanie Ulrich, Georg J. Arnold, Lars König, Dario Parazzoli, Stefan Zahler, Simon Rothenfußer, Doris Mayr, Alexander Gerbes, Giorgio Scita, Angelika M. Vollmar, Johanna Pachmayr – 23 July 2018 – Therapeutic options for patients with advanced‐stage hepatocellular carcinoma (HCC) are very limited.
Issue Information ‐ Author Checklist
23 July 2018